Sign In

Login

Password

Forgot Password ? Sign Up

Linezolid (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Linezolid" in Polish language version.

refsWebsite
Global rank Polish rank
10nih.gov
4th place
7th place
9doi.org
2nd place
6th place
1web.archive.org
1st place
1st place
1iczmp.edu.pl
low place
low place
1fda.gov
447th place
1,118th place
1medscape.com
719th place
1,030th place

doi.org

  • Grau S., Rubio-Terrés C. Pharmacoeconomics of linezolid. „Expert opinion on pharmacotherapy”. 6 (9), s. 987–1000, 2008. DOI: 10.1517/14656566.9.6.987. PMID: 18377341. 
  • Tsiodras S., Gold HS., Sakoulas G., Eliopoulos GM., Wennersten C., Venkataraman L., Moellering RC., Ferraro MJ. Linezolid resistance in a clinical isolate of Staphylococcus aureus. „Lancet”. 9277 (358), s. 207–208, 2001. DOI: 10.1016/S0140-6736(01)05410-1. PMID: 11476839. 
  • von der Lippe B., Sandven P., Brubakk O. Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)--a report of ten cases. „The Journal of infection”. 2 (52), s. 92–96, 2006. DOI: 10.1016/j.jinf.2005.04.007. PMID: 15907341. 
  • Park IN., Hong SB., Oh YM., Kim MN., Lim CM., Lee SD., Koh Y., Kim WS., Kim DS., Kim WD., Shim TS. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis. „The Journal of antimicrobial chemotherapy”. 3 (58), s. 701–704, 2006. DOI: 10.1093/jac/dkl298. PMID: 16857689. 
  • Fortún J., Martín-Dávila P., Navas E., Pérez-Elías MJ., Cobo J., Tato M., De la Pedrosa EG., Gómez-Mampaso E., Moreno S. Linezolid for the treatment of multidrug-resistant tuberculosis. „The Journal of antimicrobial chemotherapy”. 1 (56), s. 180–185, 2005. DOI: 10.1093/jac/dki148. PMID: 15911549. 
  • Lin YH., Wu VC., Tsai IJ., Ho YL., Hwang JJ., Tsau YK., Wu CY., Wu KD., Hsueh PR. High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency. „International journal of antimicrobial agents”. 4 (28), s. 345–51, 2006. DOI: 10.1016/j.ijantimicag.2006.04.017. PMID: 16935472. 
  • Plachouras D., Giannitsioti E., Athanassia S., Kontopidou F., Papadopoulos A., Kanellakopoulou K., Giamarellou H. No effect of pyridoxine on the incidence of myelosuppression during prolonged linezolid treatment. „Clinical infectious diseases : an official publication of the Infectious Diseases Society of America”. 9 (43), s. e89–91, 2006. DOI: 10.1086/508280. PMID: 17029128. 
  • Soriano A., Miró O., Mensa J. Mitochondrial toxicity associated with linezolid. „The New England journal of medicine”. 21 (353), s. 2305–2306, 2005. DOI: 10.1056/NEJM200511243532123. PMID: 16306535. 
  • Chao CC., Sun HY., Chang YC., Hsieh ST. Painful neuropathy with skin denervation after prolonged use of linezolid. „Journal of neurology, neurosurgery, and psychiatry”. 1 (79), s. 97–99, 2008. DOI: 10.1136/jnnp.2007.127910. PMID: 17766431. 

fda.gov

accessdata.fda.gov

iczmp.edu.pl

medscape.com

nih.gov

ncbi.nlm.nih.gov

  • Burkhardt O., Pletz MW., Mertgen CP., Welte T. Linezolid – the first oxazolidinone in the treatment of nosocomial MRSA pneumonia. „Recent patents on anti-infective drug discovery”. 2 (2), s. 123–130, 2007. PMID: 18221168. 
  • Grau S., Rubio-Terrés C. Pharmacoeconomics of linezolid. „Expert opinion on pharmacotherapy”. 6 (9), s. 987–1000, 2008. DOI: 10.1517/14656566.9.6.987. PMID: 18377341. 
  • Tsiodras S., Gold HS., Sakoulas G., Eliopoulos GM., Wennersten C., Venkataraman L., Moellering RC., Ferraro MJ. Linezolid resistance in a clinical isolate of Staphylococcus aureus. „Lancet”. 9277 (358), s. 207–208, 2001. DOI: 10.1016/S0140-6736(01)05410-1. PMID: 11476839. 
  • von der Lippe B., Sandven P., Brubakk O. Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)--a report of ten cases. „The Journal of infection”. 2 (52), s. 92–96, 2006. DOI: 10.1016/j.jinf.2005.04.007. PMID: 15907341. 
  • Park IN., Hong SB., Oh YM., Kim MN., Lim CM., Lee SD., Koh Y., Kim WS., Kim DS., Kim WD., Shim TS. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis. „The Journal of antimicrobial chemotherapy”. 3 (58), s. 701–704, 2006. DOI: 10.1093/jac/dkl298. PMID: 16857689. 
  • Fortún J., Martín-Dávila P., Navas E., Pérez-Elías MJ., Cobo J., Tato M., De la Pedrosa EG., Gómez-Mampaso E., Moreno S. Linezolid for the treatment of multidrug-resistant tuberculosis. „The Journal of antimicrobial chemotherapy”. 1 (56), s. 180–185, 2005. DOI: 10.1093/jac/dki148. PMID: 15911549. 
  • Lin YH., Wu VC., Tsai IJ., Ho YL., Hwang JJ., Tsau YK., Wu CY., Wu KD., Hsueh PR. High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency. „International journal of antimicrobial agents”. 4 (28), s. 345–51, 2006. DOI: 10.1016/j.ijantimicag.2006.04.017. PMID: 16935472. 
  • Plachouras D., Giannitsioti E., Athanassia S., Kontopidou F., Papadopoulos A., Kanellakopoulou K., Giamarellou H. No effect of pyridoxine on the incidence of myelosuppression during prolonged linezolid treatment. „Clinical infectious diseases : an official publication of the Infectious Diseases Society of America”. 9 (43), s. e89–91, 2006. DOI: 10.1086/508280. PMID: 17029128. 
  • Soriano A., Miró O., Mensa J. Mitochondrial toxicity associated with linezolid. „The New England journal of medicine”. 21 (353), s. 2305–2306, 2005. DOI: 10.1056/NEJM200511243532123. PMID: 16306535. 
  • Chao CC., Sun HY., Chang YC., Hsieh ST. Painful neuropathy with skin denervation after prolonged use of linezolid. „Journal of neurology, neurosurgery, and psychiatry”. 1 (79), s. 97–99, 2008. DOI: 10.1136/jnnp.2007.127910. PMID: 17766431. 

web.archive.org